OPKO Health (LTS:0KCS) Cyclically Adjusted Revenue per Share: $1.96 (As of Mar. 2026)


LTS:0KCS OPKO Health Inc LTS:0KCS
57 GF Score
Price $1.43
GF Value $1.06
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is OPKO Health Cyclically Adjusted Revenue per Share?

OPKO Health LTS:0KCS -2.84% 57 Cyclically Adjusted Revenue per Share is $1.96 as of Mar. 2026. GuruFocus rates LTS:0KCS with a GF Score™ of 57/100 and a GF Value™ of $1.06 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

OPKO Health's adjusted revenue per share for the three months ended in Mar. 2026 was $0.164. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $1.96 for the trailing ten years ended in Mar. 2026.

During the past 12 months, OPKO Health's average Cyclically Adjusted Revenue Growth Rate was -3.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 22.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of OPKO Health was 57.00% per year. The lowest was -3.90% per year. And the median was 23.30% per year.

As of today (2026-07-09), OPKO Health's current stock price is $1.43. OPKO Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $1.96. OPKO Health's Cyclically Adjusted PS Ratio of today is 0.73.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of OPKO Health was 29.97. The lowest was 0.48. And the median was 2.20.


OPKO Health  (LTS:0KCS) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

OPKO Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.43/1.96
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of OPKO Health was 29.97. The lowest was 0.48. And the median was 2.20.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


OPKO Health Cyclically Adjusted Revenue per Share Related Terms


OPKO Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for OPKO Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health Cyclically Adjusted Revenue per Share Chart

OPKO Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.52 4.91 1.88 2.01 2.01

OPKO Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.03 2.03 1.99 2.01 1.96

LTS:0KCS vs PSNL, CDNA, CSTL: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, OPKO Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where OPKO Health's Cyclically Adjusted PS Ratio falls into.


LTS:0KCS
57GF Score
OPKO Health Inc LTS:0KCS
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OPKO Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OPKO Health's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.164/330.2130*330.2130
=0.164

Current CPI (Mar. 2026) = 330.2130.

OPKO Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.641 241.018 0.878
201609 0.540 241.428 0.739
201612 0.297 241.432 0.406
201703 0.477 243.801 0.646
201706 0.519 244.955 0.700
201709 0.440 246.819 0.589
201712 0.288 246.524 0.386
201803 0.456 249.554 0.603
201806 0.471 251.989 0.617
201809 0.446 252.439 0.583
201812 0.387 251.233 0.509
201903 0.379 254.202 0.492
201906 0.386 256.143 0.498
201909 0.390 256.759 0.502
201912 0.360 256.974 0.463
202003 0.330 258.115 0.422
202006 0.470 257.797 0.602
202009 0.668 260.280 0.847
202012 0.772 260.474 0.979
202103 0.851 264.877 1.061
202106 0.684 271.696 0.831
202109 0.592 274.310 0.713
202112 0.615 278.802 0.728
202203 0.499 287.504 0.573
202206 0.435 296.311 0.485
202209 0.240 296.808 0.267
202212 0.247 296.797 0.275
202303 0.316 301.836 0.346
202306 0.353 305.109 0.382
202309 0.238 307.789 0.255
202312 0.242 306.746 0.261
202403 0.246 312.332 0.260
202406 0.261 314.175 0.274
202409 0.174 315.301 0.182
202412 0.271 315.605 0.284
202503 0.223 319.799 0.230
202506 0.199 322.561 0.204
202509 0.194 324.800 0.197
202512 0.194 324.054 0.198
202603 0.164 330.213 0.164

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $1.96 mean?
OPKO Health (LTS:0KCS) has a Cyclically Adjusted Revenue per Share of $1.96 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on OPKO Health and its competitors.
Is OPKO Health's Cyclically Adjusted Revenue per Share too high?
OPKO Health's current Cyclically Adjusted Revenue per Share is $1.96. Overall, OPKO Health has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's Cyclically Adjusted Revenue per Share compare to PSNL and CDNA?
OPKO Health's Cyclically Adjusted Revenue per Share of $1.96 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on OPKO Health and its competitors. OPKO Health's current Cyclically Adjusted Revenue per Share is $1.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (LTS:0KCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.06, compared to a current price of $1.43 — trading 34.9% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $1.96. OPKO Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For OPKO Health (LTS:0KCS), the current Cyclically Adjusted Revenue per Share is $1.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OPKO Health (LTS:0KCS) Overvalued in 2026?

Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued. The current stock price of $1.43 is trading 34.9% above its estimated GF Value™ of $1.06. GuruFocus considers OPKO Health to be Significantly Overvalued.

Key valuation signals for LTS:0KCS:

  • Cyclically Adjusted Revenue per Share: $1.96
  • GF Value™: $1.06 vs. price of $1.43 (34.9% above fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the LTS:0KCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OPKO Health Business Description

Address 4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
57GF Score

Get the complete analysis for LTS:0KCS

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.43
Price
$1.06
GF Value